HD-OPM Archive
Topics › Insulin resistance & diabetes

Metformin raises exercise metabolite Lac-Phe, addressing lactate worry

Louis Nervegna · Apr 15, 2026 · ♥ 10 reactions · 2 comments · original Facebook post
Insulin resistance & diabetes
AI summary & key facts

Louis counters the claim that metformin is bad because it raises lactate, noting intense exercise also raises lactate and that a 2026 EMBO Molecular Medicine study found metformin raises the anti-obesogenic metabolite Lac-Phe, formed during exercise, in prostate cancer patients.

I’ve heard people argue that metformin is bad for you because it raises lactate levels.

Intense exercise also raises lactate.

In fact, newer research suggests certain byproducts of lactate formed during intense exercise contribute to the metabolic benefits of the exercise.

The same byproducts of lactate are formed after taking metformin.

Link to the full study:

Paper · EMBO Mol Med · 2026The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patientsRandomized clinical trials have highlighted the importance of weight control and exercise in improving cancer outcomes, yet the molecular mediators of these benefits remain poorly understood. Recent studies in Type 2 diabetic patients reported that the insulin-sensitizing drug, metformin, exerts its anorexigenic and anti-obesogenic effects through elevation of N-lactoyl-phenylalanine (Lac-Phe), a metabolite also…link.springer.com

Links to media coverage on the study:

  1. Metformin elevates anti-obesogenic metabolite Lac-Phe in prostate cancer | Urology Times (urologytimes.com)
  1. Diabetes drug metformin echo benefits (medicalxpress.com)
  1. Metformin boosts an exercise-linked metabolite and may help control weight in prostate… (News-Medical)

Quoted (from #2):

“Lac‑Phe is produced when the body is under metabolic demand. It forms when lactate—a substance that accumulates during exertion—combines with phenylalanine, a basic building block of protein. Scientists first took notice of Lac‑Phe because its levels spike after intense exercise, coinciding with shifts in energy use and appetite regulation.

In preclinical and early human studies, higher Lac‑Phe levels have been associated with reduced appetite and improved weight control—two effects commonly linked to regular physical activity.

Lac-Phe does not rise only with exercise. Scientists observed elevated Lac-Phe levels in people taking metformin, even in the absence of physical activity.”

Quoted (from #3):

“Evidence from clinical studies suggests that weight control and exercise improve cancer outcomes, yet the mechanisms underlying these effects remain poorly understood. Metformin, a widely prescribed medication that improves insulin sensitivity, has been linked to increased Lac-Phe levels, which may influence appetite and weight regulation. These observations suggest that metformin may mimic some of the exercise-related metabolic benefits in cancer patients.”

#metforminHD #lactateHD #exerciseHD #lacpheHD

Research cited

Shared from Oxcloth · original post

A diabetes drug millions already take may replicate what happens inside your body during exercise.

Scientists at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, published a study in April 2026 in the journal EMBO Molecular Medicine that stopped the research world in its tracks.

They found that metformin, one of the most prescribed medications on the planet with over 150 million prescriptions written every year, raises levels of a molecule called Lac-Phe in patients who are completely inactive.

Lac-Phe, known in full as N-lactoyl-phenylalanine, is a compound that forms when lactate, the byproduct of physical exertion, combines with phenylalanine, an amino acid. Scientists have long known that Lac-Phe spikes dramatically after intense exercise and is directly tied to appetite regulation and weight control.

But then the team discovered something remarkable. Prostate cancer patients taking metformin who were not exercising at all showed Lac-Phe levels that matched those previously recorded after strenuous physical activity.

The reason connects to how metformin works at a cellular level. The drug inhibits complex 1 of the mitochondrial electron transport chain, which forces the body into a simulated low-energy state. This activates AMPK, the same energy-sensing enzyme that exercise triggers. In other words, metformin fools the body into thinking it has just worked out.

The finding matters most for people whose conditions prevent them from exercising. Hormone therapy for prostate cancer causes severe fatigue that stops patients from staying active, cutting off one of the most reliable tools for managing weight and metabolic health during treatment.

But then there is a complication the headlines are not always mentioning. Separate research from Rutgers University, led by professor Steven Malin and published in the Journal of Clinical Endocrinology and Metabolism, found that metformin can actually blunt the benefits of real exercise. Patients on the drug who exercised did not gain the same cardiovascular and blood vessel improvements as those who exercised without it.

So the picture is more complicated than a simple exercise pill. Metformin may offer metabolic benefits when you cannot move, but it may limit the gains you make when you can.

No photo description available.
← newer: Stuart Phillips: protein benefit for muscle plateaus around older: Weight loss, especially visceral fat loss, is the best way t →